Bevacizumab Biosimilar: Global Market Trends and Insights 2025-2033

a adăugat un sunet Health

2025-06-25 11:18:48 -

The Bevacizumab Biosimilar Market is on the rise, driven by a surge in global cancer cases and an increasing demand for affordable biologic treatments. With the original Avastin patent now expired, innovative biosimilars like Mvasi, Zirabev, and Abevmy are emerging as key players, making significant waves, particularly in the oncology sector. Healthcare systems are seizing the opportunity to...

0 Commentarii 0 Distribuiri 453 Views 0 previzualizare